407 related articles for article (PubMed ID: 29655833)
1. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus.
Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ
Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833
[TBL] [Abstract][Full Text] [Related]
2. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
[TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review.
Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM
Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.
Wani S; Rubenstein JH; Vieth M; Bergman J
Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561
[TBL] [Abstract][Full Text] [Related]
5. Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study.
Sami SS; Ravindran A; Kahn A; Snyder D; Santiago J; Ortiz-Fernandez-Sordo J; Tan WK; Dierkhising RA; Crook JE; Heckman MG; Johnson ML; Lansing R; Ragunath K; di Pietro M; Wolfsen H; Ramirez F; Fleischer D; Wang KK; Leggett CL; Katzka DA; Iyer PG
Gut; 2019 Aug; 68(8):1379-1385. PubMed ID: 30635408
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
Wolfson P; Ho KMA; Wilson A; McBain H; Hogan A; Lipman G; Dunn J; Haidry R; Novelli M; Olivo A; Lovat LB;
Gastrointest Endosc; 2022 Aug; 96(2):223-233. PubMed ID: 35189088
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
[TBL] [Abstract][Full Text] [Related]
9. Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most.
Cotton CC; Shaheen NJ; Thrift AP
Am J Gastroenterol; 2022 Jul; 117(7):1056-1062. PubMed ID: 35435856
[TBL] [Abstract][Full Text] [Related]
10. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Incidence of Intestinal Metaplasia and Dysplasia of Gastric Cardia in Patients With Barrett's Esophagus After Endoscopic Therapy.
Eluri S; Earasi AG; Moist SE; Dellon ES; Shaheen NJ
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):82-88.e1. PubMed ID: 31077822
[TBL] [Abstract][Full Text] [Related]
12. Persistent intestinal metaplasia after endoscopic eradication therapy of neoplastic Barrett's esophagus increases the risk of dysplasia recurrence: meta-analysis.
Sawas T; Alsawas M; Bazerbachi F; Iyer PG; Wang KK; Murad MH; Katzka DA
Gastrointest Endosc; 2019 May; 89(5):913-925.e6. PubMed ID: 30529044
[TBL] [Abstract][Full Text] [Related]
13. Multi-focal dysplasia is associated with high recurrence rates after successful ablation of dysplastic Barrett's esophagus.
Sapoznikov B; Fisch G; Shamah S; Shinhar N; Benjaminov F; Levi Z; Peleg N
Dig Liver Dis; 2023 Dec; 55(12):1667-1672. PubMed ID: 37517963
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett's Esophagus With Radiofrequency Ablation.
Guthikonda A; Cotton CC; Madanick RD; Spacek MB; Moist SE; Ferrell K; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2017 Jan; 112(1):87-94. PubMed ID: 27725648
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation.
Tan MC; Kanthasamy KA; Yeh AG; Kil D; Pompeii L; Yu X; El-Serag HB; Thrift AP
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):65-72.e5. PubMed ID: 29902646
[TBL] [Abstract][Full Text] [Related]
18. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett's esophagus: results from the United States Radiofrequency Ablation Registry.
Li N; Pasricha S; Bulsiewicz WJ; Pruitt RE; Komanduri S; Wolfsen HC; Chmielewski GW; Corbett FS; Chang KJ; Shaheen NJ
Dis Esophagus; 2016 Aug; 29(6):537-43. PubMed ID: 26121935
[TBL] [Abstract][Full Text] [Related]
19. Surveillance in Barrett's esophagus: an audit of practice.
Ajumobi A; Bahjri K; Jackson C; Griffin R
Dig Dis Sci; 2010 Jun; 55(6):1615-21. PubMed ID: 19669878
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
